Skip to main content
. Author manuscript; available in PMC: 2021 Mar 31.
Published in final edited form as: Immunohorizons. 2019 Jun 4;3(6):186–193. doi: 10.4049/immunohorizons.1900016

Figure 5.

Figure 5.

TLR4KO mice gained responsiveness to LPS after the i.v. injection of exosomes from WT BMDCs. Measurement of TNFα and IL-6 in the serum (A-D), spleen (E-H) and mesenteric lymph nodes (MLN) (I-L) of WT and TLR4KO mice after the injection of exosomes and LPS (the results are expressed as the mean ± SEM of measurements from N=6–12 per group, and each dot represents a measurement from one animal; *p<0.05, **p<0.01, ***p<0.001).